BMS - Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Dapagliflozin in Type 1 Diabetes
Public ClinicalTrials.gov record NCT01498185. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo-controlled, Parallel Group, Phase 2 Trial to Explore the Safety, Pharmacokinetics and Pharmacodynamics of Dapagliflozin as an Add-on to Insulin Therapy in Subjects With Type 1 Diabetes Mellitus
Study identification
- NCT ID
- NCT01498185
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- AstraZeneca
- Industry
- Enrollment
- 171 participants
Conditions and interventions
Conditions
Interventions
- Dapagliflozin Drug
- Placebo matching Dapagliflozin Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 31, 2012
- Primary completion
- Sep 30, 2012
- Completion
- Sep 30, 2012
- Last update posted
- Feb 9, 2017
2012
United States locations
- U.S. sites
- 12
- U.S. states
- 9
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Profil Institute For Clinical Research, Inc. | Chula Vista | California | 91911 | — |
| Va San Diego Healthcare System | San Diego | California | 92161 | — |
| La Biomed Research Inst. At Harbor Ucla Med Ctr. | Torrance | California | 90502 | — |
| Compass Research Phase 1, Llc | Orlando | Florida | 32806 | — |
| Progressive Medical Research | Port Orange | Florida | 32127 | — |
| Vince And Associates Clinical Research | Overland Park | Kansas | 66212 | — |
| Central Kentucky Research Associates, Inc. | Lexington | Kentucky | 40509 | — |
| Louisiana Research Associates, Inc. | New Orleans | Louisiana | 70114 | — |
| Jasper Clinic, Inc. | Kalamazoo | Michigan | 49007 | — |
| Kansas City University Of Medicine And Biosciences | Kansas City | Missouri | 64106 | — |
| Regional Medical Clinic-Endocrinology | Rapid City | South Dakota | 57701 | — |
| Dallas Diabetes & Endocrine Center | Dallas | Texas | 75230 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01498185, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 9, 2017 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01498185 live on ClinicalTrials.gov.